Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Indian Clinical Trial Market Set for Stupendous Growth

Sep 21, 2010
Share |
 
According to our research report Booming Clinical Trials Market in India”, Indian clinical trial market has experienced fast growth rate in the past few years. In 2009, the country's clinical trials market enjoyed good momentum despite global recession on the back of cost competitiveness and human resources. With presence of huge potential, it is expected that the Indian Clinical Trial market will grow at a CAGR of around 31% during the forecast period.
 
Our report identifies that, Indian clinical trial market hold fraction of share in global market in past, which is projected to increase on the back of number of major factors discussed. Besides, it has been observed that with the increasing trend of outsourcing clinical trials, the private investments in the sector have also increased. Most of these investments are aimed at setting up clinical trial facilities in the country through joint ventures. These upcoming investments projected to be done by many big international pharmaceutical and biotech firms will further create huge opportunities for the domestic industry.
 
Presently, government owned labs and privately held clinics dominates the clinical research market in the country, but this trend is anticipated to change in coming years on the back of various factors discussed in report. Our research provides a thorough analysis of the Indian clinical trial industry. Besides, the report provides complete details of the cost involved in various phases of clinical trials in the country.
 
Booming Clinical Trials Market in India provides detail information about the expenses associated with different clinical trial phases. It also reveals about the contribution of the government regulations in the growth of the country’s clinical trial industry. Further, report identifies risk factors that can affect the future growth of the industry. Competitive landscape is also provided in the report to enable clients understand future market structure and growth potential. Due consideration has been given to the possible aftereffects of the recession on the industry while making the report.  

For more information visit: http://www.rncos.com/Report/IM564.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports